ETAA16 Inhibitors
ETAA16 inhibitors, as understood in this context, are chemicals that may indirectly modulate the activity of the ETAA16 protein through their primary interactions with DNA repair and replication stress pathways. By targeting critical enzymes and components within these processes, such as PARP by Olaparib or Topoisomerase I by Camptothecin, the cellular landscape of DNA damage and replication stress is significantly altered. This change can cascade through the cellular machinery, possibly impacting the function and activity of ETAA16, especially if it plays roles in these processes.
For instance, by causing a stalling of replication forks, Olaparib challenges proteins like ETAA16 if they're involved in fork stabilization. Similarly, Hydroxyurea induces replication stress by depleting dNTP pools, which can affect replication-associated proteins, including ETAA16. Another angle of interaction is through cell cycle modulation, as with Nocodazole, where the disruption to the cell cycle might indirectly influence proteins associated with DNA repair or replication. The essence of these inhibitors lies not in their direct targeting of ETAA16, but in their potential to reshape the functional environment in which ETAA16 operates.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
PARP inhibitor that prevents the repair of single-strand breaks, thus causing stalling of replication forks. If ETAA16 is involved in fork stabilization, its activity can be indirectly impacted by an accumulation of stalled forks. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibits Topoisomerase I, trapping it in a cleavage complex and preventing DNA unwinding. This leads to replication stress and can influence proteins, potentially including ETAA16, that respond to such stress. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Inhibits Topoisomerase II, causing double-strand breaks. If ETAA16 plays a role in double-strand break repair, it could be impacted by the increase in these lesions. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Disrupts microtubules, leading to cell cycle arrest. This may indirectly influence DNA repair proteins, including potentially ETAA16, due to alterations in cell cycle progression. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Inhibits ribonucleotide reductase, causing a depletion of dNTPs and stalling replication. Replication-associated proteins, possibly ETAA16, can be affected by the resultant replication stress. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Metabolized into nucleotide analogs that get incorporated into DNA, causing mispairing and replication stress. This can challenge DNA repair proteins, potentially including ETAA16. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Inhibits DNA polymerases, leading to replication stalling. Such stalling can influence proteins associated with replication fork stabilization, including potentially ETAA16. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $275.00 | 5 | |
Induces DNA breaks. If ETAA16 is involved in the DNA damage response or repair, it can be impacted by the increase in DNA lesions. | ||||||
SCH 900776 | 891494-63-6 | sc-364611 sc-364611A | 5 mg 10 mg | $255.00 $338.00 | ||
Inhibits CHK1, essential for cell cycle checkpoints in response to DNA damage. Altered checkpoint signaling can influence downstream repair proteins, potentially including ETAA16. | ||||||